Afluria Quadrivalent is an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine.

* Afluria Quadrivalent 2022-23 is approved for use in persons 36 months of age and older.